MARKET

DCOY

DCOY

DECOY THERAPEUTICS INC
NASDAQ
0.7801
+0.0101
+1.31%
Opening 09:47 01/09 EST
OPEN
0.7746
PREV CLOSE
0.7700
HIGH
0.7899
LOW
0.7611
VOLUME
59.56K
TURNOVER
--
52 WEEK HIGH
108.00
52 WEEK LOW
0.5148
MARKET CAP
4.57M
P/E (TTM)
-0.0199
1D
5D
1M
3M
1Y
5Y
1D
*News On Salarius Pharmaceuticals Inc. (SLRX) Now Under DCOY
Dow Jones · 23h ago
Salarius Pharmaceuticals changes corporate name to Decoy Therapeutics
TipRanks · 2d ago
Salarius Pharmaceuticals Changes Corporate Name To Decoy Therapeutics, Nasdaq Ticker To DCOY, Effective Jan. 8
Benzinga · 2d ago
SALARIUS PHARMACEUTICALS INC - TRADING UNDER DCOY TO COMMENCE ON JANUARY 8, 2026
Reuters · 2d ago
Salarius Pharmaceuticals Rebrands as Decoy Therapeutics
Reuters · 2d ago
Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics
Barchart · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 4d ago
More
About DCOY
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. It is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold.

Webull offers Salarius Pharmaceuticals Inc stock information, including NASDAQ: DCOY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DCOY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DCOY stock methods without spending real money on the virtual paper trading platform.